Abstract:Background and Aims: microRNAs (miRNAs) are involved in the pathogenesis of multiple human cancers, including CRC.Dysregulation of global miRNA profiles, which often associates with loss of expression of certain miRNAs, is a common feature in CRC.Whereas CpG island hypermethylation has been proposed to be a potential mechanism for miRNA silencing, this field remains largely unexplored.In this study, we describe the epigenetic regulation of miR-137 and its contribution to colorectal carcinogenesis.Methods: We determined the methylation status of the miR-137 CpG island in a panel of six CRC cell lines and 409 colorectal tissues (21 normal colonic mucosae from healthy individuals (N-N), 160 primary CRC tissues with corresponding adjacent normal colonic mucosa (N-C) and 68 colonic adenomas) by bisulfite pyrosequencing.TaqMan RT-PCR and in situ hybridization (ISH) were used to analyze miR-137 expression.In Vitro functional analysis of miR-137 was performed using precursor-miRNA transfection.Downstream genetic targets of miR-137 were identified by gene expression microarray analysis in combination with in silico predictions.Western blotting and luciferase assays were performed to validate the miRNA:mRNA interactions.Results: Methylation of the miR-137 CpG island was frequent in CRC cell lines (100%), adenomas (82.3%) and CRCs (81.4%) but not in N-C (14.4%; p<0.0001 for CRC) and N-N (4.7%; p<0.0001 for CRC).When compared to miR-137 unmethylated tumors, methylated CRCs were more frequently associated with KRAS mutations (37% vs 14%; p= 0.046) and older age (66 vs 60 years; p= 0.024).ISH results revealed that miR-137 expression was restricted to the colonocytes in normal mucosa, and was absent in CRC tissues.TaqMan RT-PCR analysis showed an inverse correlation between methylation and expression both in CRC tissues and cell lines.Transfection of the miR-137 precursor into CRC cell lines significantly decreased the cell proliferation index (p=0.0029).Functional assays validated an interaction between miR-137 and LSD-1, which plays a crucial role in the maintenance of DNA methylation.Conclusions: Our data suggest that miR-137 acts as a tumor suppressor in the colon, and is frequently silenced by promoter hypermethylation.Frequent methylation found in adenomatous polyps suggests it is an early event in colorectal carcinogenesis.The interaction between miR-137 and LSD-1 suggests a mechanistic explanation for these observations and highlights the potential significance of this tumor-suppressive miRNA in epigenetic processes in colorectal tumorigenesis.

Methylation of NRIP3 is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.

Methylation of NRIP3 is a synthetic lethal marker for combined PI3K and ATR/ATM inhibitors in CRC

Igfbp-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage Ii Colorectal Cancers

Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer

Value of CNRIP1 promoter methylation in colorectal cancer screening and prognosis assessment and its influence on the activity of cancer cells

Epigenetic Silencing Oflrrc3bin Colorectal Cancer

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Polymeric Immunoglobulin Receptor Suppresses Colorectal Cancer Through the AKT-FOXO3/4 Axis by Downregulating LAMB3 Expression

Downregulation of ZNF365 by Methylation Predicts Poor Prognosis in Patients with Colorectal Cancer by Decreasing Phospho-P53 (ser15) Expression

RNA-binding protein IMP3 is a novel regulator of MEK1/ERK signaling pathway in the progression of colorectal Cancer through the stabilization of MEKK1 mRNA

Retinoic Acid-Induced 2 (RAI2) is a Novel Tumor Suppressor, and Promoter Region Methylation of RAI2 is a Poor Prognostic Marker in Colorectal Cancer.

CpG island methylation of BNIP3 predicts resistance against S-1/CPT-11 combined therapy in colorectal cancer patients

A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors

An Oncogenic Gene, SNRPA1, Regulates PIK3R1, VEGFC, MKI67, CDK1 and Other Genes in Colorectal Cancer.

LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer.

NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK

Nuclear receptor subfamily 3 group c member 2 (NR3C2) is downregulated due to hypermethylation and plays a tumor-suppressive role in colon cancer

682 Inactivation of T-Box 5 (Tbx5) Gene in Colon Cancer and Its Potential Application

Methyltransferase 3A-Mediated Promoter Methylation Represses Retinoic Acid Receptor Responder 3 Expression in Basal-Like Breast Cancer

Biomarker RIPK3 Is Silenced by Hypermethylation in Melanoma and Epigenetic Editing Reestablishes Its Tumor Suppressor Function

m 6 A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.